drug transparency

First Round of Oregon v. Pharma. State Publishes Data And Stories. Next Up: Trade Secrets

This article is for premium subscribers. Please sign up here for a tax-deductible subscription. 

If you're a premium subscriber, sign in below. 

An Oregon program that aims to peel back the opaque layers of prescription drug pricing wrapped up its first year this week with a report to the Legislature that underlines

Subscribe to drug transparency